Literature DB >> 3432602

Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat.

M Heilig1, R Murison.   

Abstract

Effects of intracerebroventricular administration of neuropeptide Y on open field behaviour, behavioural habituation and corticosterone response to open field testing, and on home cage activity have been investigated in the rat. In the open field, NPY reduced activity in a dose-dependent manner. Behavioural habituation was not influenced. After 5 days of recovery, NPY-treated animals did not differ from non-treated in any of the measured parameters. Peripheral corticosterone levels were not significantly affected, although there was a strong tendency towards an increase. Injection of 2 nmol NPY did not produce any gross neurological deficits. At this dose, NPY greatly suppressed home cage activity. The effect lasted throughout the recording period of 22 h, abolishing the normal circadian variation in activity. After 5 days of recovery, the effect was no longer present. Our interpretation of these findings is, that NPY is a highly potent endogenous agent capable of producing certain important aspects of behavioural sedation in a reversible manner. Since NPY did not decrease the corticosterone response to a novel stimulus, its pattern of actions seems to differ from synthetic sedative drugs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3432602     DOI: 10.1016/0167-0115(87)90278-3

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  13 in total

1.  Overexpression of neuropeptide Y decreases responsiveness to neuropeptide Y.

Authors:  Katelynn M Corder; Qin Li; Mariana A Cortes; Aundrea F Bartley; Taylor R Davis; Lynn E Dobrunz
Journal:  Neuropeptides       Date:  2019-11-07       Impact factor: 3.286

2.  Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models.

Authors:  M Heilig; B Söderpalm; J A Engel; E Widerlöv
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 3.  Neuropeptide modulation of central amygdala neuroplasticity is a key mediator of alcohol dependence.

Authors:  Nicholas W Gilpin; Marisa Roberto
Journal:  Neurosci Biobehav Rev       Date:  2011-11-11       Impact factor: 8.989

4.  Neuropeptide Y Regulates Sleep by Modulating Noradrenergic Signaling.

Authors:  Chanpreet Singh; Jason Rihel; David A Prober
Journal:  Curr Biol       Date:  2017-12-07       Impact factor: 10.834

5.  Centrally administered neuropeptide Y (NPY) inhibits gastric emptying and intestinal transit in the rat.

Authors:  M Matsuda; M Aono; M Moriga; M Okuma
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

6.  Effects of centrally administered neuropeptide Y (NPY) and NPY13-36 on the brain monoaminergic systems of the rat.

Authors:  M Heilig; L Vècséi; C Wahlestedt; C Alling; E Widerlöv
Journal:  J Neural Transm Gen Sect       Date:  1990

7.  NPY Y1 receptors differentially modulate GABAA and NMDA receptors via divergent signal-transduction pathways to reduce excitability of amygdala neurons.

Authors:  Andrei I Molosh; Tammy J Sajdyk; William A Truitt; Weiguo Zhu; Gerry S Oxford; Anantha Shekhar
Journal:  Neuropsychopharmacology       Date:  2013-01-28       Impact factor: 7.853

8.  Evidence from knockout mice that peptide YY and neuropeptide Y enforce murine locomotion, exploration and ingestive behaviour in a circadian cycle- and gender-dependent manner.

Authors:  Martin E Edelsbrunner; Herbert Herzog; Peter Holzer
Journal:  Behav Brain Res       Date:  2009-05-03       Impact factor: 3.332

9.  Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro.

Authors:  S Greber; C Schwarzer; G Sperk
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

10.  Neuropeptide Y suppresses ethanol drinking in ethanol-abstinent, but not non-ethanol-abstinent, Wistar rats.

Authors:  Nicholas W Gilpin; Robert B Stewart; Nancy E Badia-Elder
Journal:  Alcohol       Date:  2008-11       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.